You can buy or sell FBIO and other stocks, options, ETFs, and crypto commission-free!
Fortress Biotech, Inc. engages in the development and commercialization of novel pharmaceutical and biotechnology products. It operates through the following segments: Dermatology Product Sales, Pharmaceutical and Biotechnology Product Development, and National. Read More The National segment consists of National Holdings Corporation, an independent brokerage company. The company was founded on June 28, 2006 in and is headquartered in New York, NY.
New York, New York
52 Week High
52 Week Low
Guru FocusMar 14
Fortress Biotech to Present at the 31st Annual ROTH Conference
NEW YORK, March 14, 2019 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. ( FBIO) (“Fortress”), an innovative biopharmaceutical company focused on identifying, in-licensing and developing high-potential clinical-stage assets, today announced that Lindsay A. Rosenwald, M.D., Chairman, President and Chief Executive Officer, will present a company overview at the 31st Annual ROTH Conference. The presentation will take place on Tuesday, March 19, 2019, at 3:00 p.m. PDT at The Ritz-Carlton, Laguna Niguel in Dana Point...
Yahoo FinanceMar 14
All You Need to Know About Fortress Biotech (FBIO) Rating Upgrade to Strong Buy
Fortress Biotech (FBIO) has been upgraded to a Zacks Rank 1 (Strong Buy), reflecting growing optimism about the company's earnings prospects.
Simply Wall StMar 4
Those Who Purchased Fortress Biotech Shares A Year Ago Have A 53% Loss To Show For It
It is a pleasure to report that the Fortress Biotech, Inc. (NASDAQ:FBIO) is up 65% in the last quarter. But that doesn’t change the fact that the returns over the last year have been disappointing. During that time the share price has sank like a stone, descending 53%. It’s not that amazing to see a bounce after a drop like that. Arguably, the fall was overdone. See our latest analysis for Fortress Biotech Fortress Biotech isn’t a profitable company, so it is unlikely we’ll see a strong correlation betwee...
-$0.58 per share
Available Mar 18, Pre-Market